Funded Tech Companies

Portola Pharmaceuticals

Operating out of South San Francisco, Portola Pharmaceuticals raised its funding from Temasek Holdings, private investors and BBT Fund.

Company Overview

Contact Information

Company Background Information

Overview

Portola Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease. Portola has two drug candidates in clinical development.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/22/2013

Financing History

Management Team

Title

Name

Email & Social

Chief Financial Officer

Mard Dier

        

Chief Medical Officer

John Lawrence?

        

VP - Bus. Development

Tao Fu

        

VP - Engineering

Glenn Brame

        

VP - General Counsel

John Moriarty

        

VP - R & D

John Curnutte

        

Company Investors

• Temasek Holdings
• BBT Fund
• Adage Capital Management
• D. E. Shaw Group
• Pac-Link Bio
• AllianceBernstein
• Brookside Capital
• Frazier Healthcare Partners (Alan Frazier)
• Advanced Technology Ventures (Jean George)
• Abingworth (Michael Bigham)
• MPM Capital (Nicholas Galakatos)
• CID Capital
• Alta Partners (Farah Champsi)
• Prospect Venture Partners (Russell Hirsch)
• Sutter Hill Ventures (Jeffrey Bird)
• Goldman Sachs

Browse more funded tech companies:

Portofino Technologies | Porton Advanced Solutions

Share this article

About Our VC Deals Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary